The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
(B.1.1.529) variant of concern (VOC) has destabilized global efforts to control the impact …

Therapeutic T cells with desired specificity can be engineered by introducing T-cell receptors
(TCRs) specific for antigens of interest, such as those from pathogens or tumour cells. …

Adoptive transfer of T cells expressing a transgenic T cell receptor (TCR) has the potential to
revolutionize immunotherapy of infectious diseases and cancer. However, the generation of …

Many immunocompromised patients mount suboptimal humoral immunity after SARS-CoV-2
mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T …

Suboptimal immunity to SARS-CoV-2 mRNA vaccination has frequently been observed in
individuals with various immunodeficiencies. Given the increased antibody evasion properties …

Adaptive evolution is a key feature of T cell immunity. During acute immune responses, T
cells harboring high-affinity T cell antigen receptors (TCRs) are preferentially expanded, but …

Following genotoxic stress, cells activate a complex signalling network to arrest the cell cycle
and initiate DNA repair or apoptosis. The tumour suppressor p53 lies at the heart of this …

Introduction: This randomized phase II trial evaluated single-agent pemetrexed or sequential
pemetrexed/gemcitabine in patients with non-small cell lung cancer (NSCLC) who were …

Objective Transgenic re‐expression enables unbiased investigation of T‐cell receptor (TCR)‐intrinsic
characteristics detached from its original cellular context. Recent advancements in …

Background Since its inception, SARS-CoV-2 has continued to impose unprecedented
challenges on the medical and scientific communities. The complex and ever-evolving nature of …